Amid ongoing uncertainty around funding for the NIH and what it could mean for U.S. innovation, a top Merck executive ...

The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...

The use of Gilead’s Trodelvy and Merck’s Keytruda together could be practice-changing based on the results of a new study ...

Researchers estimated 7.5% more U.S. children would get cavities, affecting 25.4 million additional teeth, if fluoridation ...

Summit Therapeutics said its closely tracked antibody, the first lung cancer drug to beat Merck’s Keytruda in a head-to-head ...

The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...

Philip Morris is rolling out a heated tobacco product called IQOS in the U.S., concerning researchers and anti-tobacco ...

Budget documents for Congress provide the most detailed look yet at how the Trump Administration hopes to reshape the ...

HHS has notified Moderna that it is canceling a nearly $600 million contract for vaccines for flu strains that could trigger ...

This is a historic moment in decades-long efforts to appropriately address the needs of the hundreds of millions worldwide ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

The combined impacts of an immigration crackdown and slashing Medicaid budgets could create an exodus of long-term care ...